<DOC>
	<DOCNO>NCT01959828</DOCNO>
	<brief_summary>Sixteen Japanese subject ( 6 adults/10 child ) peri- post-operative pulmonary hypertension associate cardiac surgery evaluate approx . 6 site safety efficacy IK-3001 .</brief_summary>
	<brief_title>Confirmatory Study IK-3001 Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc . With Cardiac Surgery</brief_title>
	<detailed_description>This multi-center , open-label , clinical study safety efficacy IK-3001 16 subject peri- post-operative pulmonary hypertension associate cardiac surgery . Two primary sub-sets patient population evaluate study : 1 . Adults severe congestive heart failure LVAD implant 2 . Children require surgery congenital heart disease correspond PH Glenn surgery Fontan surgery single-ventricle physiology . Children severe pulmonary hypertension due congenital heart disease require inhaled nitric oxide ( iNO ) pre-operatively may also enrol .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>1 . Subjects must meet one follow criterion : 1 . Adults , age 15 80 year , severe congestive heart failure ( CHF ) schedule leave ventricular assist device ( LVAD ) placement ; 2 . Children , age &lt; 15 year , schedule surgery congenital heart disease may associate pulmonary hypertension ( PH ) ( include child severe PH due congenital heart failure severe hypoxemia secondary high pulmonary vascular resistance either history possibility develop PH crisis , deem investigator subinvestigator require IK3001 preoperatively ) ; 3 . Children , age &lt; 15 year , congenital heart disease schedule Glenn surgery ; 4 . Children , age &lt; 15 year , congenital heart disease schedule Fontan surgery . 2 . For woman childbearing potential , negative result pregnancy test document prior enrollment . 3 . Subjects must give write informed consent . If subject minor subject 's legally acceptable representative ( parent legal guardian ) must give write informed consent . 1 . Lung hypoplasia preexist severe lung disease ; 2 . Planned biventricular support ; 3 . Participation another clinical trial investigational agent within 28 day day inform consent study include subject deem carry residual effect investigational product last 28 day previous investigational study ; 4 . Subjects PH secondary organic obstructive lesion pulmonary artery ; 5 . Subjects mechanical ventilation ; 6 . Investigator subinvestigator decision subject unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>pulmonary hypertension</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>Glenn surgery</keyword>
	<keyword>fontan surgery</keyword>
	<keyword>leave ventricular assist device</keyword>
	<keyword>LVAD</keyword>
</DOC>